Psychedelic Startups See Green Rush as Mental Health Uses Mushroom

With a recent boom in psychedelic research, a new wave of startups aims to capitalize on mind-altering compounds like psilocybin for wide-ranging mental health applications. A growing body of evidence suggests psychedelics may help treat conditions like depression, PTSD, and addiction. As attitudes and regulations loosen, investors and entrepreneurs see dollar signs in shrooms.